Amylyx Pharmaceuticals, Inc.

	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19
Total revenue	0.00	0.09	0.38	0.02	0.00	0.00	0.00
Cost of revenue	0.00	0.04	0.03	0.00	0.00	0.02	0.01
Gross profit	0.00	0.05	0.36	0.02	0.00	-0.02	-0.01
Total operating expenses +	0.15	0.36	0.32	0.22	0.08	0.02	0.01
Selling, general and administrative	0.06	0.11	0.18	0.13	0.04	0.01	0.00
Research and development	0.09	0.10	0.13	0.09	0.04	0.02	0.01
Other operating expenses	0.00	0.14	0.01	0.00	0.00	-0.02	0.00
Operating income	-0.15	-0.31	0.04	-0.20	-0.08	-0.04	-0.01
Non-operating income (net)	0.01	0.01	0.02	0.00	-0.01	0.00	0.00
Income before tax	-0.14	-0.30	0.05	-0.20	-0.09	-0.04	-0.01
Income tax expense	0.00	0.00	0.01	0.00	0.00	0.00	0.00
Net income	-0.14	-0.30	0.05	-0.20	-0.09	-0.04	-0.01

Show Quarterly Income Statement

	Mar-26	Dec-25	Sep-25	Jun-25	Mar-25	Dec-24	Sep-24	Jun-24	Mar-24	Dec-23	Sep-23	Jun-23	Mar-23	Dec-22	Sep-22	Jun-22	Mar-22	Dec-21	Sep-21	Jun-21	Mar-21	Dec-20
Total revenue	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.09	0.11	0.10	0.10	0.07	0.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cost of revenue	0.00	0.00	0.02	0.00	0.00	0.00	0.00	0.01	0.12	0.01	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.01	0.00	0.00	0.01
Gross profit	0.00	0.00	-0.02	0.00	0.00	0.00	0.00	-0.01	-0.03	0.10	0.10	0.09	0.07	0.02	0.00	0.00	0.00	0.00	-0.01	0.00	0.00	0.00
Total operating expenses +	0.04	0.04	0.02	0.04	0.04	0.04	0.08	0.04	0.09	0.10	0.08	0.07	0.07	0.06	0.05	0.05	0.05	0.03	0.02	0.02	0.01	0.01
Selling, general and administrative	0.02	0.02	0.02	0.02	0.02	0.01	0.02	0.02	0.06	0.04	0.05	0.04	0.04	0.06	0.03	0.03	0.03	0.01	0.01	0.01	0.01	0.00
Research and development	0.03	0.02	0.02	0.03	0.02	0.02	0.02	0.02	0.04	0.04	0.03	0.03	0.02	0.02	0.02	0.02	0.02	0.01	0.01	0.01	0.01	0.01
Other operating expenses	0.00	0.00	-0.02	0.00	0.00	0.00	0.04	0.00	0.00	0.01	0.00	0.00	0.00	-0.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating income	-0.04	-0.04	-0.04	-0.04	-0.04	-0.04	-0.08	-0.05	-0.12	0.00	0.02	0.02	0.00	-0.04	-0.05	-0.05	-0.05	-0.03	-0.02	-0.02	-0.01	-0.01
Non-operating income (net)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Income before tax	-0.04	-0.03	-0.03	-0.04	-0.04	-0.04	-0.07	-0.07	-0.12	0.01	0.02	0.02	0.00	-0.04	-0.05	-0.05	-0.05	-0.03	-0.02	-0.02	-0.01	-0.01
Income tax expense		0.00				0.00	-0.07		0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net income	-0.04	-0.03	-0.03	-0.04	-0.04	-0.04	-0.07	-0.07	-0.12	0.00	0.02	0.02	0.00	-0.04	-0.05	-0.05	-0.05	-0.03	-0.02	-0.02	-0.01	-0.01

4 days ago

Ask a follow up

	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19
Total cash and short-term investments +	0.32	0.18	0.37	0.35	0.10	0.01	0.00
Cash and cash equivalents	0.23	0.08	0.17	0.06	0.05	0.01	0.00
Short-term investments	0.09	0.10	0.20	0.28	0.05	0.00
Accounts receivable, net	0.00	0.00	0.04	0.02	0.00
Inventories		0.00	0.04	0.01	0.00
Other current assets	0.01	0.01	0.01	0.01	0.01	0.00	0.00
Total current assets	0.32	0.19	0.46	0.38	0.10	0.01	0.00
Total non-current assets +	0.01	0.00	0.05	0.01	0.00	0.00	0.00
Property, plant and equipment, net				0.00	0.00	0.00
Goodwill
Intangible assets
Long-term investments
Other non-current assets
Total assets	0.33	0.19	0.52	0.39	0.11	0.01	0.00

Total current liabilities +	0.02	0.03	0.08	0.05	0.02	0.01	0.00
Accounts payable	0.00	0.00	0.02	0.01	0.00	0.00	0.00
Short-term debt	0.00	0.00	0.00	0.00
Current portion of long-term debt
Deferred revenue
Other current liabilities	0.02	0.02	0.06	0.04	0.01	0.00	0.00
Total non-current liabilities +	0.00	0.00	0.00	0.00	0.24	0.07	0.02
Long-term debt						0.00	0.01
Capital lease obligations	0.01	0.00	0.00	0.01	0.00
Other non-current liabilities				0.00	0.00
Total liabilities	0.03	0.03	0.08	0.05	0.26	0.08	0.03

Total stockholders' equity +	0.31	0.16	0.43	0.34	-0.15	-0.07	-0.03
Common stock and paid-in capital	1.06	0.77	0.74	0.69	0.00	0.00	0.00
Retained earnings	-0.75	-0.61	-0.30	-0.35	-0.16	-0.07	-0.03
Common shares outstanding	95	68	70	67	58	56	56

Show Quarterly Balance Sheet

	Mar-26	Dec-25	Sep-25	Jun-25	Mar-25	Dec-24	Sep-24	Jun-24	Mar-24	Dec-23	Sep-23	Jun-23	Mar-23	Dec-22	Sep-22	Jun-22	Mar-22	Dec-21	Sep-21	Jun-21	Mar-21	Dec-20
Total cash and short-term investments +	0.28	0.32	0.34	0.18	0.20	0.18	0.23	0.31	0.37	0.37	0.36	0.36	0.35	0.35	0.16	0.21	0.26	0.10	0.13	0.00	0.01	0.01
Cash and cash equivalents	0.23	0.23	0.23	0.06	0.06	0.08	0.07	0.07	0.17	0.17	0.14	0.25	0.11	0.06	0.11	0.07	0.11	0.05	0.08		-0.01	0.01
Short-term investments	0.05	0.09	0.12	0.12	0.14	0.10	0.16	0.23	0.20	0.20	0.22	0.11	0.23	0.28	0.05	0.14	0.14	0.05	0.05		0.03
Accounts receivable, net		0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.02	0.04	0.03	0.03	0.02	0.02	0.00
Inventories						0.00	0.00	0.00	0.00	0.04	0.03	0.02	0.01	0.01	0.00
Other current assets	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.02	0.01	0.02	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.00			0.00
Total current assets	0.29	0.32	0.35	0.19	0.22	0.19	0.25	0.33	0.41	0.46	0.43	0.43	0.39	0.38	0.17	0.22	0.27	0.10	0.13		0.01	0.01
Total non-current assets +	0.01	0.01	0.01	0.01	0.00	0.00	0.01	0.01	0.01	0.05	0.03	0.03	0.02	0.01	0.01	0.01	0.01	0.00	0.00		-0.01	0.00
Property, plant and equipment, net												0.01	0.01	0.00	0.01	0.00	0.00	0.00				0.00
Goodwill
Intangible assets
Long-term investments
Other non-current assets
Total assets	0.29	0.33	0.36	0.19	0.22	0.19	0.25	0.33	0.42	0.52	0.47	0.45	0.41	0.39	0.18	0.23	0.27	0.11	0.13			0.01

Total current liabilities +	0.02	0.02	0.03	0.02	0.02	0.03	0.05	0.07	0.09	0.08	0.05	0.06	0.05	0.05	0.03	0.03	0.03	0.02	0.02			0.01
Accounts payable	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.02	0.02	0.01	0.02	0.01	0.01	0.01	0.01	0.01	0.00	0.00			0.00
Short-term debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00		0.00
Current portion of long-term debt																			0.00
Deferred revenue
Other current liabilities	0.01	0.02	0.02	0.02	0.01	0.02	0.05	0.06	0.07	0.06	0.04	0.04	0.04	0.04	0.02	0.02	0.02	0.01	0.01			0.00
Total non-current liabilities +	0.00	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.01	0.24	0.24			0.07
Long-term debt																						0.00
Capital lease obligations	0.01	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.01	0.01	0.01	0.01	0.01
Other non-current liabilities													0.00	0.00	0.00	0.01	0.01
Total liabilities	0.02	0.03	0.03	0.03	0.02	0.03	0.05	0.07	0.09	0.08	0.05	0.07	0.06	0.05	0.04	0.03	0.03	0.26	0.25			0.08

Total stockholders' equity +	0.27	0.31	0.33	0.17	0.20	0.16	0.20	0.26	0.32	0.43	0.42	0.39	0.35	0.34	0.14	0.19	0.24	-0.15	-0.12		0.01	-0.07
Common stock and paid-in capital	1.07	1.06	1.05	0.85	0.84	0.77	0.77	0.76	0.75	0.74	0.73	0.72	0.71	0.69	0.46	0.45	0.44	0.00	0.00	0.00	0.01	0.00
Retained earnings	-0.79	-0.75	-0.72	-0.68	-0.64	-0.61	-0.57	-0.50	-0.42	-0.30	-0.31	-0.33	-0.35	-0.35	-0.31	-0.26	-0.20	-0.16	-0.13			-0.07
Common shares outstanding	111	95	93	89	86	69	68	68	68	69	70	70	71	65	59	58	52	55	55	46	46	46

4 days ago

Ask a follow up

	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19
Operating cash flow +	-0.12	-0.17	0.01	-0.18	-0.07	-0.04	-0.01
Net income
Depreciation, depletion and amortization	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Stock-based compensation	0.03	0.03	0.04	0.02	0.00	0.00	0.00
Change in inventory	0.00	-0.01	-0.07	-0.01	-0.01	-0.01	-0.01
Other working capital changes	-0.15	-0.19	0.05	-0.19	-0.07	-0.03	0.00
Cash flow from investing +	0.01	0.08	0.09	-0.24	-0.05	0.00	0.00
Capital expenditures	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Others incl. marketable securities changes	0.01	0.08	0.09	-0.24	-0.05	0.00	0.00
Cash flow from financing +	0.26	0.00	0.00	0.43	0.16	0.05	0.00
Dividend payout
Common stock repurchases			0.00	0.43
Net Debt Issuance	0.26	0.00	0.01	0.00	0.16	0.05	0.00

Change in cash	0.15	-0.09	0.11	0.01	0.04	0.01	-0.01

Show Quarterly Cash Flow

	Mar-26	Dec-25	Sep-25	Jun-25	Mar-25	Dec-24	Sep-24	Jun-24	Mar-24	Dec-23	Sep-23	Jun-23	Mar-23	Dec-22	Sep-22	Jun-22	Mar-22	Dec-21	Sep-21	Jun-21	Mar-21	Dec-20
Operating cash flow +	-0.04	-0.03	-0.03	-0.03	-0.04	-0.06	-0.04	-0.07	0.00	0.01	-0.01	0.01	-0.01	-0.05	-0.04	-0.05	-0.04	-0.03	-0.02	-0.01	-0.01	-0.01
Net income
Depreciation, depletion and amortization	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Stock-based compensation	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00
Change in inventory		0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.01	-0.03	-0.01	-0.02	-0.01	-0.01	0.00	0.00	0.00	0.00
Other working capital changes	-0.04	-0.03	-0.04	-0.03	-0.05	-0.07	-0.05	-0.08	0.00	0.03	0.00	0.02	0.00	-0.05	-0.05	-0.05	-0.04	-0.03	-0.02	-0.01	-0.01	-0.01
Cash flow from investing +	0.04	0.03	0.01	0.02	-0.04	0.06	0.04	-0.03	0.00	0.02	-0.11	0.12	0.06	-0.23	0.08	0.00	-0.10	0.00	-0.05	0.00	0.00	0.00
Capital expenditures	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Others incl. marketable securities changes	0.04	0.03	0.01	0.02	-0.04	0.07	0.04	-0.03	0.00	0.02	-0.11	0.12	0.06	-0.23	0.08	0.01	-0.10	0.00	-0.05	0.00	0.00	0.00
Cash flow from financing +	0.00	0.00	0.19	0.00	0.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.23	0.20	0.00	0.20	0.00	0.13	0.00	0.03	0.00
Dividend payout
Common stock repurchases					0.00		0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.23		0.00	0.20
Net Debt Issuance	0.00	0.00	0.19	0.00	0.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.20	0.00	0.00	0.00	0.13	0.00	0.03	0.00

Change in cash	0.00	0.00	0.17	0.00	-0.02	0.01	0.00	-0.10	0.00	0.03	-0.11	0.13	0.05	-0.05	0.24	-0.04	0.06	-0.03	0.06	-0.01	0.01	-0.01